18F-FEDAC作为活化巨噬细胞靶向探针在胶原诱导性关节炎DBA/1小鼠中的应用:与18F-FDG的比较
研究在脂多糖活化的RAW 264.7巨噬细胞和胶原诱导性关节炎DBA/1小鼠中评估18F-FEDAC靶向TSPO显像的可行性,并与18F-FDG比较。活化巨噬细胞TSPO表达及18F-FEDAC摄取增高并可被PK11195阻断;关节炎关节18F-FEDAC摄取在第23天早期即增高而18F-FDG未见增高,第37天18F-FDG摄取明显增高并高于18F-FEDAC。
要点
- 活化巨噬细胞TSPO mRNA和蛋白表达增高,18F-FEDAC摄取高于未活化细胞并可被PK11195阻断。
- CIA小鼠关节炎关节18F-FEDAC摄取在第23天早期即增高,而18F-FDG摄取未增高。
- 第37天18F-FDG摄取明显增高并高于18F-FEDAC,且与summed severity score强相关(P<0.001,r=0.897)。
核心结论
- 18F-FEDAC通过靶向活化巨噬细胞的TSPO表达,可在CIA模型中显示关节炎关节的活动性炎症部位。
- 结果提示18F-FEDAC显像在RA早期阶段具有潜在应用价值。
研究设计与样本
- 体外研究使用脂多糖活化的RAW 264.7小鼠巨噬细胞,以定量聚合酶链反应和Western blotting检测TSPO表达,用γ计数器测定18F-FEDAC的细胞摄取与特异性结合。
- 体内研究在DBA/1小鼠建立胶原诱导性关节炎(CIA),定期测定关节炎临床评分,于首次免疫后第23天和第37天采集18F-FEDAC与18F-FDG PET图像,并行组织学检查评估巨噬细胞与TSPO表达。
主要发现
- 活化巨噬细胞中TSPO信使RNA和蛋白表达增高,活化巨噬细胞对18F-FEDAC的摄取高于未活化细胞,且可被竞争剂PK11195成功阻断。
- CIA小鼠首次免疫后第26天出现关节肿胀,至第37天病情加重。
- 关节炎关节18F-FEDAC摄取在早期(第23天)即增高,而18F-FDG摄取未增高;第37天18F-FDG摄取明显增高,高于18F-FEDAC摄取。
- 18F-FEDAC摄取与summed severity score呈弱相关(P=0.019,r=0.313),18F-FDG摄取与summed severity score呈强相关(P<0.001,r=0.897)。
- 关节炎关节组织切片显示巨噬细胞浸润较正常关节增多。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activated macrophages have been known to play pivotal roles in the pathogenesis of rheumatoid arthritis (RA). 18F-FEDAC (N-benzyl-N-methyl-2-[7,8-dihydro-7-(2-18F-fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide) is a radiolabeled ligand for the 18-kDa translocator protein (TSPO), which is abundant in activated macrophages. We evaluated the feasibility of using 18F-FEDAC in a murine RA model. Methods: RAW 264.7 mouse macrophages were activated by lipopolysaccharide. TSPO expression levels in activated and inactivated macrophages were measured by quantitative polymerase chain reaction and Western blotting. The cellular uptake and specific binding of 18F-FEDAC were measured using a γ-counter. For the in vivo study, collagen-induced arthritis (CIA) was developed in DBA/1 mice, and the clinical score for arthritis was measured regularly. 18F-FEDAC and 18F-FDG PET images were acquired on days 23 and 37 after the first immunization. Histologic examinations were performed to evaluate macrophages and TSPO expression. Results: We found increased TSPO messenger RNA and protein expression in activated macrophages. Uptake of 18F-FEDAC in activated macrophages was higher than that in nonactivated cells and was successfully blocked by the competitor, PK11195. In CIA mice, joint swelling was apparent on day 26 after the first immunization, and the condition worsened by day 37. 18F-FEDAC uptake by arthritic joints increased early on (day 23), whereas 18F-FDG uptake did not. However, 18F-FDG uptake by arthritic joints markedly increased at later stages (day 37) to a higher level than 18F-FEDAC uptake. The 18F-FEDAC uptake correlated weakly with summed severity score (P = 0.019, r = 0.313), whereas the 18F-FDG uptake correlated strongly with summed severity score (P < 0.001, r = 0.897). Histologic sections of arthritic joints demonstrated an influx of macrophages compared with that in normal joints. Conclusion:18F-FEDAC enabled the visualization of active inflammation sites in arthritic joints in a CIA model by targeting TSPO expression in activated macrophages. The results suggest the potential usefulness of 18F-FEDAC imaging in the early phase of RA.
引用
- Chung SJ, Yoon HJ, Youn H, et al. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG. J Nucl Med. 2018. PMID: 29326355. doi:10.2967/jnumed.117.200667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。